Ligand validation:5GV4

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5GV4_EDO_A_303	84%	78%	0.076	0.937	0.42	0.47	-	-	0	0	100%	1
5GV4_EDO_A_305	38%	75%	0.127	0.827	0.47	0.51	-	-	1	0	100%	1
5GV4_EDO_A_302	37%	83%	0.193	0.891	0.41	0.38	-	-	0	0	100%	1
5GV4_EDO_A_306	35%	76%	0.198	0.886	0.33	0.61	-	-	2	0	100%	1
5GV4_EDO_A_304	5%	90%	0.342	0.76	0.5	0.12	-	-	0	0	100%	1
5BMW_EDO_A_305	96%	88%	0.072	0.979	0.27	0.4	-	-	0	0	100%	1
4YXG_EDO_B_301	78%	83%	0.092	0.935	0.38	0.4	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
3G7R_EDO_B_961	100%	85%	0.035	0.988	0.45	0.3	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.